CEO: | Paul Carmelo Pagano |
Chief Finance Officer: | David Mark Anderson |
Independent Non-Executive Director: | James Renwick McCullough |
Non-Executive Chairman: | Gordon Roy Davis |
Senior Independent Non-Executive Director: | Andrew Norman Boteler |
Non-Executive Dir: | Sara Barrington |
Address: | 850 New Burton Road, Suite 201, Dover, Delaware, USA, 19904 |
Website: | https://www.lunglifeai.com/ |
Sector: | Pharma and Biotech(LSE) |
Index: | FTSE AIM All-Share |
Domestic Listings: | LSE:LLA |
ISIN: | USU5500L1045 |
Currency | UK Pounds |
Share Price | 30.00p |
Change Today | -1.00p |
% Change | -3.23 % |
52 Week High | 123.00 |
52 Week Low | 19.00 |
Volume | 50,136 |
Shares Issued | 25.49m |
Market Cap | £7.65m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
10:11 | 6,500 @ 30.66p |
10:11 | 6,136 @ 29.06p |
10:03 | 15,000 @ 29.00p |
09:07 | 15,000 @ 30.00p |
08:35 | 7,500 @ 30.00p |
You are here: research